Exact Mass: 495.3325

Exact Mass Matches: 495.3325

Found 352 metabolites which its exact mass value is equals to given mass value 495.3325, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mibefradil

2-methoxyacetic acid [2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester

C29H38FN3O3 (495.2897)


C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

JI-20B

Antibiotic JI 20B

C20H41N5O9 (495.2904)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

   

(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,4R,5S,6R)-3-amino-6-[(1S)-1-aminoethyl]-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol

(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,4R,5S,6R)-3-amino-6-[(1S)-1-aminoethyl]-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol

C20H41N5O9 (495.2904)


   

Phosphatidylcholine lyso 16:0

Phosphatidylcholine lyso 16:0

C24H50NO7P (495.3325)


   

LysoPC(16:0/0:0)

(2R)-2-Hydroxy-3-(hexadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C24H50NO7P (495.3325)


LysoPC(16:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:0), in particular, consists of one chain of palmitic acid at the C-1 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(16:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:0), in particular, consists of one chain of palmitic acid at the C-1 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

   

LysoPC(0:0/16:0)

(2-{[(2R)-2-(hexadecanoyloxy)-3-hydroxypropyl phosphono]oxy}ethyl)trimethylazanium

C24H50NO7P (495.3325)


LysoPC(0:0/16:0) is a lysophosphatidylcholine, which is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2 as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. There is also a phospholipase A1, which is able to cleave the sn-1 ester bond. Lysophosphatidylcholine has pro-inflammatory properties in vitro and it is known to be a pathological component of oxidized lipoproteins (LDL) in plasma and of atherosclerotic lesions. Recently, it has been found to have some functions in cell signalling, and specific receptors (coupled to G proteins) have been identified. It activates the specific phospholipase C that releases diacylglycerols and inositol triphosphate with resultant increases in intracellular Ca2+ and activation of protein kinase C. It also activates the mitogen-activated protein kinase in certain cell types. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPC(0:0/16:0), in particular, consists of one chain of palmitic acid at the C-2 position.

   

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine

3-({7-[3,5-dihydroxy-2-(3-hydroxyocta-1,5-dien-1-yl)cyclopentyl]hept-5-enoyl}oxy)-4-(trimethylazaniumyl)butanoate

C27H45NO7 (495.3196)


(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine is an acylcarnitine. More specifically, it is an (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Cholylserine

3-hydroxy-2-(4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)propanoic acid

C27H45NO7 (495.3196)


Cholylserine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylserine consists of the bile acid cholic acid conjugated to the amino acid Serine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylserine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylserine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Chenodeoxycholylcysteine

2-(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-sulfanylpropanoic acid

C27H45NO5S (495.3018)


   

Deoxycholylcysteine

2-[(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]-3-sulphanylpropanoic acid

C27H45NO5S (495.3018)


   

1-Nonadecanoyl-glycero-3-phosphoethanolamine

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] nonadecanoate

C24H50NO7P (495.3325)


   

N(4)-Octadecyl-1-arabinofuranosylcytosine

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(octadecylamino)-1,2-dihydropyrimidin-2-one

C27H49N3O5 (495.3672)


   

Mibefradil

2-(2-{[3-(1H-1,3-benzodiazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetic acid

C29H38FN3O3 (495.2897)


   

1-Palmitoylphosphatidylcholine

(2-{[3-(hexadecanoyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium

C24H50NO7P (495.3325)


   

Sabine

6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosane-1,10,11,12,14,19,20-heptol

C27H45NO7 (495.3196)


   

20-Ethyl-1,7,8-trihydroxy-6,16-dimethoxy-4-(methoxymethyl)aconitan-14-yl acetate #

20-Ethyl-1,7,8-trihydroxy-6,16-dimethoxy-4-(methoxymethyl)aconitan-14-yl acetate #

C26H41NO8 (495.2832)


   
   

6-O-Acetyl-14-O-methyldelphinifoline

6-O-Acetyl-14-O-methyldelphinifoline

C26H41NO8 (495.2832)


   

Talitine A

O1-Methyltalitine C

C26H41NO8 (495.2832)


   

1-O-hexadecyl-2-C-methyl-3-phosphatidylcholine

1-O-hexadecyl-2-C-methyl-3-phosphatidylcholine

C25H54NO6P (495.3689)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

(1alpha,6beta,14alpha,16beta)-4-[(acetyloxy)methyl]-20-ethyl-6,14,16-trimethoxyaconitane-1,7,8-triol|1-O-demethyltricornine

(1alpha,6beta,14alpha,16beta)-4-[(acetyloxy)methyl]-20-ethyl-6,14,16-trimethoxyaconitane-1,7,8-triol|1-O-demethyltricornine

C26H41NO8 (495.2832)


   

cyclo (-Gly-L-Orn-L-Ile-3-amino-10-methyldodecanoyl-)|rhodopeptin C2

cyclo (-Gly-L-Orn-L-Ile-3-amino-10-methyldodecanoyl-)|rhodopeptin C2

C26H49N5O4 (495.3784)


   

lycoperine A

lycoperine A

C31H49N3O2 (495.3825)


An alkaloid that consists of piperidine substituted by [1-acetyl-7-methyl-1,2,3,4,6,7,8,8a-octahydroquinolin-5-yl]methyl moieties at positions 2 and 6 respectively. Isolated from Lycopodium hamiltonii, it exhibits acetylcholinesterase inhibitory activity.

   

5beta-Cevan-3beta,4alpha,12,14,16beta,17,20-heptaol|5beta-cevane-3beta,4alpha,12,14,16beta,17,20-heptaol

5beta-Cevan-3beta,4alpha,12,14,16beta,17,20-heptaol|5beta-cevane-3beta,4alpha,12,14,16beta,17,20-heptaol

C27H45NO7 (495.3196)


   
   

(-)-martinellic acid|martinellic acid

(-)-martinellic acid|martinellic acid

C27H41N7O2 (495.3322)


   
   

dysoxyhainanin A

dysoxyhainanin A

C31H45NO4 (495.3348)


A pentacyclic triterpenoid with a rearranged oleanane skeleton isolated from the whole plants of Dysoxylum hainanense. It exhibits antibacterial activity against Gram-positive bacteria.

   

cyclo (-GlyL-Orn-L-Val-3-amino-12-methyltridecanoyl-)|rhodopeptin C3

cyclo (-GlyL-Orn-L-Val-3-amino-12-methyltridecanoyl-)|rhodopeptin C3

C26H49N5O4 (495.3784)


   

1-O-benzoylkarasamine

1-O-benzoylkarasamine

C30H41NO5 (495.2985)


   
   

1-O-Hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine

1-O-Hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine

C25H54NO6P (495.3689)


   

Phosphatidylcholine lyso 16:0

Phosphatidylcholine lyso 16:0

C24H50NO7P (495.3325)


   

PC(16:0/0:0)

2-Hydroxy-3-(palmitoyloxy)propyl 2-(trimethylammonio)ethyl phosph ate

C24H50NO7P (495.3325)


CONFIDENCE standard compound; INTERNAL_ID 121 COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Serine-Cholic Acid

Serine-Cholic Acid

C27H45NO7 (495.3196)


   

Lysophosphatidylcholines, egg

(2-{[3-(hexadecanoyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium

C24H50NO7P (495.3325)


   

LPC 16:0

3-Palmitoyl-rac-glycerol-1-phosphorylcholine

C24H50NO7P (495.3325)


Annotation level-2

   
   

LPE 19:0-d5

QE [M+Hac+Na-2H]-

C24H50NO7P (495.3325)


   

Cysteine conjugated chenodeoxycholic acid

Cysteine conjugated chenodeoxycholic acid

C27H45NO5S (495.3018)


   

((4R)-4-((3R,5S,7R,10S,13R,14S)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)cysteine

"((4R)-4-((3R,5S,7R,10S,13R,14S)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)cysteine"

C27H45NO5S (495.3018)


   

1-Palmitoyl-sn-glycero-3-phosphocholine

1-Palmitoyl-sn-glycero-3-phosphocholine

C24H50NO7P (495.3325)


   

LysoPhosphatidylcholine_16_0

1-Palmitoyl-sn-glycero-3-phosphocholine

C24H50NO7P (495.3325)


   

Ala His Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Ala His Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Ala His Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Ala His Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Ala Ile His Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Ala Ile Arg His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Ala Leu His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Ala Leu Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Ala Arg His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Ala Arg His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Ala Arg Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Ala Arg Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

His Ala Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

His Ala Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

His Ala Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H37N9O5 (495.2918)


   

His Ala Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H37N9O5 (495.2918)


   

His Ile Ala Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

His Ile Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

His Ile Arg Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

His Ile Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylbutanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

His Lys Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylpentanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

His Lys Leu Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-methylpentanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

His Lys Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanamido]-3-methylpentanoic acid

C23H41N7O5 (495.3169)


   

His Lys Val Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanamido]-4-methylpentanoic acid

C23H41N7O5 (495.3169)


   

His Leu Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

His Leu Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]hexanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

His Leu Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

His Leu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylbutanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

His Arg Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]propanamido]-3-methylpentanoic acid

C21H37N9O5 (495.2918)


   

His Arg Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]propanamido]-4-methylpentanoic acid

C21H37N9O5 (495.2918)


   

His Arg Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

His Arg Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

His Val Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylpentanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

His Val Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]hexanamido]-3-methylpentanoic acid

C23H41N7O5 (495.3169)


   

His Val Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]hexanamido]-4-methylpentanoic acid

C23H41N7O5 (495.3169)


   

His Val Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-4-methylpentanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Ile Ala His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Ile Ala Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Ile His Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Ile His Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Ile His Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Ile His Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Ile Lys His Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Ile Lys Val His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Ile Arg Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Ile Arg His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Ile Val His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Ile Val Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Lys His Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Lys His Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Lys His Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Lys His Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Lys Ile His Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Lys Ile Val His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Lys Leu His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Lys Leu Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Lys Val His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Lys Val His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Lys Val Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Lys Val Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Leu Ala His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Leu Ala Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Leu His Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-5-carbamimidamidopentanoic acid

C21H37N9O5 (495.2918)


   

Leu His Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Leu His Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Leu His Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Leu Lys His Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C23H41N7O5 (495.3169)


   

Leu Lys Val His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Leu Arg Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Leu Arg His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H37N9O5 (495.2918)


   

1-Palmitoyllysophosphatidylcholine

Choline, phosphate, 1-ester with 2-monopalmitin

C24H50NO7P (495.3325)


   

Leu Val His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Leu Val Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Arg Ala His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Arg Ala His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Arg Ala Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Arg Ala Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Arg His Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Arg His Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanoic acid

C21H37N9O5 (495.2918)


   

Arg His Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Arg His Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Arg Ile Ala His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Arg Ile His Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Arg Leu Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H37N9O5 (495.2918)


   

Arg Leu His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H37N9O5 (495.2918)


   

Val His Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Val His Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Val His Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Val His Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Val Ile His Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Val Ile Lys His

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Val Lys His Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Val Lys His Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C23H41N7O5 (495.3169)


   

Val Lys Ile His

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Val Lys Leu His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

Val Leu His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H41N7O5 (495.3169)


   

Val Leu Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H41N7O5 (495.3169)


   

PC(7:0/8:0)[U]

3,5,8-Trioxa-4-phosphahexadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxoheptyl)oxy]methyl]-, inner salt, 4-oxide

C23H46NO8P (495.2961)


   

PC(8:0/7:0)[U]

3,5,9-Trioxa-4-phosphaheptadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoheptyl)oxy]-, inner salt, 4-oxide

C23H46NO8P (495.2961)


   

Platelet-activating factor

3,5,9-Trioxa-4-phosphatricosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C24H50NO7P (495.3325)


   

PC(O-1:0/O-16:0)[U]

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-7-(methoxymethyl)-N,N,N-trimethyl-, inner salt, 4-oxide

C25H54NO6P (495.3689)


   

PC(O-16:0/O-1:0)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C25H54NO6P (495.3689)


   

PC(O-16:0/O-1:0)[S]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide, (S)-

C25H54NO6P (495.3689)


   

ET 16OME

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide, (1)-

C25H54NO6P (495.3689)


   

16:0 LYSO-PC

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

C24H50NO7P (495.3325)


   

PC(16:0/0:0)[S]

Palmitin, 1-mono-, 3-(dihydrogen phosphate), monoester with choline hydroxide, inner salt, D-

C24H50NO7P (495.3325)


   

PC(16:0/0:0)[U]

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C24H50NO7P (495.3325)


   

PC(0:0/16:0)

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

C24H50NO7P (495.3325)


   

Palmi

Choline, hydroxide, dihydrogen phosphate, inner salt, 3-ester with 1-monopalmitin, L-

C24H50NO7P (495.3325)


   

PC(O-17:0/0:0)

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C25H54NO6P (495.3689)


   

PE(9:0/9:0)[U]

1,2-dinonanoyl-sn-glycero-3-phosphoethanolamine

C23H46NO8P (495.2961)


   

2-O-methyl PAF C-16

1-O-hexadecyl-2-O-methyl-sn-glyceryl-3-phosphorylcholine

C25H54NO6P (495.3689)


   

LPC(16:0)

1-Palmitoyl-glycero-3-phosphocholine

C24H50NO7P (495.3325)


   

PE(19:0/0:0)

1-nonadecanoyl-glycero-3-phosphoethanolamine

C24H50NO7P (495.3325)


   

PE(O-20:0/0:0)

1-eicosyl-glycero-3-phosphoethanolamine

C25H54NO6P (495.3689)


   

PC O-16:0

1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine

C24H50NO7P (495.3325)


   

LPC O-17:0

1-(15-methyl-)hexadecyl-sn-glycero-3-phosphocholine

C25H54NO6P (495.3689)


   

LPE 19:0

1-nonadecanoyl-glycero-3-phosphoethanolamine

C24H50NO7P (495.3325)


   

LPE O-20:0

1-eicosyl-glycero-3-phosphoethanolamine

C25H54NO6P (495.3689)


   

LPE O-19:1;O

1-(2-methoxy-6Z-octadecenyl)-sn-glycero-3-phosphoethanolamine

C24H50NO7P (495.3325)


   

Solvent Blue 5

Solvent Blue 5

C33H41N3O (495.3249)


   

methyl(trioctyl)azanium,iodide

methyl(trioctyl)azanium,iodide

C25H54IN (495.3301)


   
   

buta-1,3-diene,2-ethylhexyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enenitrile,styrene

buta-1,3-diene,2-ethylhexyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enenitrile,styrene

C31H45NO4 (495.3348)


   

Treprostinil diolamine

Treprostinil diolamine

C27H45NO7 (495.3196)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78568 - Prostaglandin Analogue

   

(3-Hexadecoxy-2-hydroxy-2-methylpropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Hexadecoxy-2-hydroxy-2-methylpropyl) 2-(trimethylazaniumyl)ethyl phosphate

C25H54NO6P (495.3689)


   

N(2)-acetylgentamycin C1a(4+)

N(2)-acetylgentamycin C1a(4+)

C21H45N5O8+4 (495.3268)


   
   

Deoxycholylcysteine

Deoxycholylcysteine

C27H45NO5S (495.3018)


   

Chenodeoxycholylcysteine

Chenodeoxycholylcysteine

C27H45NO5S (495.3018)


   

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]cyclopentyl]hept-5-enoylcarnitine

C27H45NO7 (495.3196)


   

8-[3-(Diethylamino)-1-(4-methoxyphenyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one

8-[3-(Diethylamino)-1-(4-methoxyphenyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one

C30H41NO5 (495.2985)


   

3alpha,20alpha-dihydroxy-5beta-pregnane 3-O-(beta-D-glucuronate)

3alpha,20alpha-dihydroxy-5beta-pregnane 3-O-(beta-D-glucuronate)

C27H43O8- (495.2958)


   

1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N-[3-(4-morpholinyl)propyl]-6-oxo-1-propyl-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N-[3-(4-morpholinyl)propyl]-6-oxo-1-propyl-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C27H37N5O4 (495.2845)


   

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C29H41N3O4 (495.3097)


   

1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N-[3-(4-morpholinyl)propyl]-6-oxo-1-propyl-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N-[3-(4-morpholinyl)propyl]-6-oxo-1-propyl-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C27H37N5O4 (495.2845)


   

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

C29H41N3O4 (495.3097)


   

N-hexanoylphytosphingosine 1-phosphate

N-hexanoylphytosphingosine 1-phosphate

C24H50NO7P (495.3325)


   

(2-Octanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Octanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

[(2S)-2-hexadecanoyloxy-3-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-hexadecanoyloxy-3-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] hexadecanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] hexadecanoate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] propanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] propanoate

C24H50NO7P (495.3325)


   

1-o-Heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine

1-o-Heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine

C25H54NO6P (495.3689)


   
   

2-Aminoethyl (2-hydroxy-3-icosoxypropyl) hydrogen phosphate

2-Aminoethyl (2-hydroxy-3-icosoxypropyl) hydrogen phosphate

C25H54NO6P (495.3689)


   

Lnape 9:0/N-9:0

Lnape 9:0/N-9:0

C23H46NO8P (495.2961)


   

Lnape 4:0/N-14:0

Lnape 4:0/N-14:0

C23H46NO8P (495.2961)


   

Lnape 6:0/N-12:0

Lnape 6:0/N-12:0

C23H46NO8P (495.2961)


   

Lnape 7:0/N-11:0

Lnape 7:0/N-11:0

C23H46NO8P (495.2961)


   

Lnape 16:0/N-2:0

Lnape 16:0/N-2:0

C23H46NO8P (495.2961)


   

Lnape 10:0/N-8:0

Lnape 10:0/N-8:0

C23H46NO8P (495.2961)


   

Lnape 14:0/N-4:0

Lnape 14:0/N-4:0

C23H46NO8P (495.2961)


   

Lnape 13:0/N-5:0

Lnape 13:0/N-5:0

C23H46NO8P (495.2961)


   

Lnape 12:0/N-6:0

Lnape 12:0/N-6:0

C23H46NO8P (495.2961)


   

Lnape 11:0/N-7:0

Lnape 11:0/N-7:0

C23H46NO8P (495.2961)


   

Lnape 15:0/N-3:0

Lnape 15:0/N-3:0

C23H46NO8P (495.2961)


   

Lnape 2:0/N-16:0

Lnape 2:0/N-16:0

C23H46NO8P (495.2961)


   

Lnape 3:0/N-15:0

Lnape 3:0/N-15:0

C23H46NO8P (495.2961)


   

Lnape 5:0/N-13:0

Lnape 5:0/N-13:0

C23H46NO8P (495.2961)


   

Lnape 8:0/N-10:0

Lnape 8:0/N-10:0

C23H46NO8P (495.2961)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C32H49NO3 (495.3712)


   

(2-Heptanoyloxy-3-nonoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptanoyloxy-3-nonoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] octanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] octanoate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] decanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] decanoate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] hexanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] hexanoate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] nonanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] nonanoate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] heptanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] heptanoate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] undecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] undecanoate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] acetate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] acetate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] butanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] butanoate

C24H50NO7P (495.3325)


   

(3-Decoxy-2-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decoxy-2-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

(2-Butanoyloxy-3-dodecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Butanoyloxy-3-dodecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

(2-Propanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Propanoyloxy-3-tridecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

(2-Pentanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Pentanoyloxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid

C27H45NO5S (495.3018)


   

19:0 Lyso PE-d5

19:0 Lyso PE-d5

C24H50NO7P (495.3325)


   

(2-Acetyloxy-3-tetradecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Acetyloxy-3-tetradecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C24H50NO7P (495.3325)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] pentanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] pentanoate

C24H50NO7P (495.3325)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-nonanoyloxypropyl] nonanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-nonanoyloxypropyl] nonanoate

C23H46NO8P (495.2961)


   

(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-5-phenyl-4-pentenoate

(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-5-phenyl-4-pentenoate

C34H41NO2 (495.3137)


   

(3-Heptanoyloxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptanoyloxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] pentadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] pentadecanoate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tridecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tridecanoate

C23H46NO8P (495.2961)


   

(2-Dodecanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Dodecanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] dodecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] dodecanoate

C23H46NO8P (495.2961)


   

(3-Acetyloxy-2-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Acetyloxy-2-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] undecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] undecanoate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] tetradecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] tetradecanoate

C23H46NO8P (495.2961)


   

(3-Hexanoyloxy-2-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Hexanoyloxy-2-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C23H46NO8P (495.2961)


   

(2-Decanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Decanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C23H46NO8P (495.2961)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] decanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] decanoate

C23H46NO8P (495.2961)


   

(3-Butanoyloxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C23H46NO8P (495.2961)


   

lysoDGTS 18:3

lysoDGTS 18:3

C28H49NO6 (495.356)


   

2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(nonanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[(2-Acetamido-3-hydroxyheptadecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Acetamido-3-hydroxyheptadecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[Hydroxy-[3-hydroxy-2-(octanoylamino)undecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(octanoylamino)undecoxy]phosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[[2-(Hexanoylamino)-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Hexanoylamino)-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[[2-(Butanoylamino)-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Butanoylamino)-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[[2-(Heptanoylamino)-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Heptanoylamino)-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[Hydroxy-[3-hydroxy-2-(undecanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(undecanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

2-[[2-(Decanoylamino)-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Decanoylamino)-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H52N2O6P+ (495.3563)


   

Antibiotic JI-20B

Antibiotic JI-20B

C20H41N5O9 (495.2904)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

   

N(2)-acetylgentamycin C1a(4+)

N(2)-acetylgentamycin C1a(4+)

C21H45N5O8 (495.3268)


Tetracation of N(2)-acetylgentamycin C1a.

   

2-Palmitoyl-sn-glycero-3-phosphocholine

2-Palmitoyl-sn-glycero-3-phosphocholine

C24H50NO7P (495.3325)


A lysophosphatidylcholine 16:0 in which the acyl group is specified as palmitoyl (hexadecanoyl) and is located at position 2.

   

2-methoxyacetic acid [2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester

2-methoxyacetic acid [2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester

C29H38FN3O3 (495.2897)


   

1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine

1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine

C24H50NO7P (495.3325)


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as tetradecyl.

   

1-heptadecyl-sn-glycero-3-phosphocholine

1-heptadecyl-sn-glycero-3-phosphocholine

C25H54NO6P (495.3689)


   

1-eicosyl-glycero-3-phosphoethanolamine

1-eicosyl-glycero-3-phosphoethanolamine

C25H54NO6P (495.3689)


   

1-nonadecanoyl-glycero-3-phosphoethanolamine

1-nonadecanoyl-glycero-3-phosphoethanolamine

C24H50NO7P (495.3325)


   

1-(2-methoxy-6Z-octadecenyl)-sn-glycero-3-phosphoethanolamine

1-(2-methoxy-6Z-octadecenyl)-sn-glycero-3-phosphoethanolamine

C24H50NO7P (495.3325)


   

phosphatidylethanolamine 18:0 zwitterion

phosphatidylethanolamine 18:0 zwitterion

C23H46NO8P (495.2961)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 18 carbons and no double bonds.

   

phosphatidylcholine 15:0

phosphatidylcholine 15:0

C23H46NO8P (495.2961)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 15 carbons and no double bonds.

   

lysophosphatidylcholine 16:0

lysophosphatidylcholine 16:0

C24H50NO7P (495.3325)


A lysophosphatidylcholine in which the acyl group has a fully saturated C16 chain and is attached to the glycero moiety at either position 1 or 2.

   

Lysophosphatidylcholine(0:0/16:0)

Lysophosphatidylcholine(0:0/16:0)

C24H50NO7P (495.3325)


A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 16 carbons and is fully saturated.

   

1-hexadecanoyl-sn-glycero-3-phosphocholine

1-hexadecanoyl-sn-glycero-3-phosphocholine

C24H50NO7P (495.3325)


A lysophosphatidylcholine 16:0 in which a hexadecanoyl (palmitoyl) group is attached to the glycero moiety at position 1.

   

PC(15:0)

PC(4:0_11:0)

C23H46NO8P (495.2961)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

LdMePE(17:0)

LdMePE(17:0)

C24H50NO7P (495.3325)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

LdMePE(18:0)

LdMePE(18:0(1))

C25H54NO6P (495.3689)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PE(19:0)

PE(8:0(1)_11:0)

C24H50NO7P (495.3325)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Tyr 22:4(7Z,10Z,13Z,16Z)

NA-Tyr 22:4(7Z,10Z,13Z,16Z)

C31H45NO4 (495.3348)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

CerP 14:0;O2/10:0;O

CerP 14:0;O2/10:0;O

C24H50NO7P (495.3325)


   
   
   
   
   
   
   
   
   
   

ST 24:2;O6;Gly

ST 24:2;O6;Gly

C26H41NO8 (495.2832)


   

ST 25:1;O5;Gly

ST 25:1;O5;Gly

C27H45NO7 (495.3196)


   

ST 26:0;O4;Gly

ST 26:0;O4;Gly

C28H49NO6 (495.356)


   

ST 28:6;O3;Gly

ST 28:6;O3;Gly

C30H41NO5 (495.2985)


   

ST 29:5;O2;Gly

ST 29:5;O2;Gly

C31H45NO4 (495.3348)


   

ST 18:1;O3;HexNAc

ST 18:1;O3;HexNAc

C26H41NO8 (495.2832)


   

ST 19:0;O2;HexNAc

ST 19:0;O2;HexNAc

C27H45NO7 (495.3196)


   
   

2-{[(1-{[(3z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylbutanoic acid

2-{[(1-{[(3z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylbutanoic acid

C24H41N5O6 (495.3057)


   

(1r,3s,4r,9r,10r,12s,13r,14s,17s,19s,21r)-3,6,10,13,14,19-hexamethyl-24,27-dioxa-23-azaheptacyclo[11.10.3.1¹⁷,²¹.0¹,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²³]heptacos-6-ene-8,11,25-trione

(1r,3s,4r,9r,10r,12s,13r,14s,17s,19s,21r)-3,6,10,13,14,19-hexamethyl-24,27-dioxa-23-azaheptacyclo[11.10.3.1¹⁷,²¹.0¹,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²³]heptacos-6-ene-8,11,25-trione

C30H41NO5 (495.2985)


   

11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

C26H41NO8 (495.2832)


   

11-ethyl-8-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-yl benzoate

11-ethyl-8-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-yl benzoate

C30H41NO5 (495.2985)


   

6-(3-aminopropyl)-13-(7-methylnonyl)-3-(sec-butyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

6-(3-aminopropyl)-13-(7-methylnonyl)-3-(sec-butyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C26H49N5O4 (495.3784)


   

aconitum kirinense alkaloid

NA

C26H41NO8 (495.2832)


{"Ingredient_id": "HBIN014585","Ingredient_name": "aconitum kirinense alkaloid","Alias": "NA","Ingredient_formula": "C26H41NO8","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7188","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2r,3r,4r,5r,6s,8r,9r,10r,13r,16s,17s,18s)-11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

(1r,2r,3r,4r,5r,6s,8r,9r,10r,13r,16s,17s,18s)-11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

C26H41NO8 (495.2832)


   

(2-{[(2r)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[(2r)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium

C24H50NO7P (495.3325)


   

{11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl acetate

{11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl acetate

C26H41NO8 (495.2832)


   

(2s,3s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-phenylpropylidene]amino}-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]-3-methylpentanimidic acid

(2s,3s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-phenylpropylidene]amino}-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]-3-methylpentanimidic acid

C29H41N3O4 (495.3097)


   

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-yl benzoate

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-yl benzoate

C30H41NO5 (495.2985)


   

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate

C26H41NO8 (495.2832)


   

(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

C26H41NO8 (495.2832)


   

(3s,6s,13r)-6-(3-aminopropyl)-3-isopropyl-13-(9-methyldecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3s,6s,13r)-6-(3-aminopropyl)-3-isopropyl-13-(9-methyldecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C26H49N5O4 (495.3784)


   

(1r,2r,3r,4r,5r,6r,8r,9r,10r,13r,16s,17s,18s)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1r,2r,3r,4r,5r,6r,8r,9r,10r,13r,16s,17s,18s)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

14-ethyl-4,6,19-trimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane-2,3-diol

14-ethyl-4,6,19-trimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane-2,3-diol

C26H41NO8 (495.2832)


   

2-({1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-phenylpropylidene}amino)-n-(1-hydroxy-3-phenylpropan-2-yl)-3-methylpentanimidic acid

2-({1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-phenylpropylidene}amino)-n-(1-hydroxy-3-phenylpropan-2-yl)-3-methylpentanimidic acid

C29H41N3O4 (495.3097)


   

(3s,6s)-6-(3-aminopropyl)-13-(7-methylnonyl)-3-(sec-butyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3s,6s)-6-(3-aminopropyl)-13-(7-methylnonyl)-3-(sec-butyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C26H49N5O4 (495.3784)


   

(3as,4s,9bs)-4-{3-[n'-(3-methylbut-2-en-1-yl)carbamimidamido]propyl}-1-[n-(3-methylbut-2-en-1-yl)carbamimidoyl]-2h,3h,3ah,4h,5h,9bh-pyrrolo[3,2-c]quinoline-8-carboxylic acid

(3as,4s,9bs)-4-{3-[n'-(3-methylbut-2-en-1-yl)carbamimidamido]propyl}-1-[n-(3-methylbut-2-en-1-yl)carbamimidoyl]-2h,3h,3ah,4h,5h,9bh-pyrrolo[3,2-c]quinoline-8-carboxylic acid

C27H41N7O2 (495.3322)


   

6-(3-aminopropyl)-3-isopropyl-13-(9-methyldecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

6-(3-aminopropyl)-3-isopropyl-13-(9-methyldecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C26H49N5O4 (495.3784)


   

11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

(1s,2r,3r,4s,5r,6s,8r,9s,10r,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1s,2r,3r,4s,5r,6s,8r,9s,10r,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18r)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18r)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

(3s,6s)-6-(3-aminopropyl)-3-isopropyl-13-(9-methyldecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3s,6s)-6-(3-aminopropyl)-3-isopropyl-13-(9-methyldecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C26H49N5O4 (495.3784)


   

(1s,2r,3r,4r,5r,6s,8r,9s,10s,13s,16r,17r,18r)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1s,2r,3r,4r,5r,6s,8r,9s,10s,13s,16r,17r,18r)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

(3s,6s,13r)-6-(3-aminopropyl)-13-(7-methylnonyl)-3-(sec-butyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3s,6s,13r)-6-(3-aminopropyl)-13-(7-methylnonyl)-3-(sec-butyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C26H49N5O4 (495.3784)


   

2-[({1-[(2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6-trien-8-yl)-c-hydroxycarbonimidoyl]-2-methylpropyl}-c-hydroxycarbonimidoyl)amino]-3-methylbutanoic acid

2-[({1-[(2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6-trien-8-yl)-c-hydroxycarbonimidoyl]-2-methylpropyl}-c-hydroxycarbonimidoyl)amino]-3-methylbutanoic acid

C24H41N5O6 (495.3057)


   

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C26H41NO8 (495.2832)


   

(2-{[(2r)-2-hydroxy-3-[(15-methylhexadecyl)oxy]propyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[(2r)-2-hydroxy-3-[(15-methylhexadecyl)oxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C25H54NO6P (495.3689)


   

(3s,6s,9r)-13-heptyl-5,8,11-trihydroxy-3-isopropyl-6,9-bis(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

(3s,6s,9r)-13-heptyl-5,8,11-trihydroxy-3-isopropyl-6,9-bis(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C27H49N3O5 (495.3672)


   

[(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate

[(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-4,6,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate

C26H41NO8 (495.2832)